Franklin Resources Inc Next Cure, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.29 - $1.84 $6,542 - $9,332	-5,072 Reduced 20.57%	19,588 $25,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.19 $1,025 - $1,956	377 Added 1.55%	24,660 $68,000
Q2 2022 Aug 11, 2022	SELL	$3.38 - $5.27 $39,265 - $61,221	-11,617 Reduced 32.36%	24,283 $114,000
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $1,904 - $2,496	400 Added 1.13%	35,900 $174,000
Q4 2021 Feb 11, 2022	BUY	$5.7 - $9.1 $202,350 - $323,050	35,500 New	35,500 $213,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.